Anumana
PrivateLast Round
Series C
Apr 24, 2025
Total Funding Raised
$181.1M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Anumana operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series C round in April 2025.
Anumana is a health technology company that develops AI-driven ECG algorithms to enhance early diagnosis and treatment through advanced predictive tools and biomarkers of disease.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anumana Comparables
Compare Anumana with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pathway Labs | 84% | |
| GE HealthCare Technologies Inc. | 82% | |
| HEARTio | 81% |
For institutional investors. Book with your work email.
Anumana Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 24, 2025 | ||||
| Series B | Jun 1, 2022 | ||||
| Series A | Apr 14, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Anumana Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Matrix | Series C, Series B, Series A |
| Matrix Capital Management | Series C, Series A |
| NTTVC | Series C, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 124% MoM, reaching 9.4K.
- Apr 8, 2026
FDA-cleared AI software for cardiac amyloidosis diagnosis launched.
For institutional investors. Book with your work email.
Anumana Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Anumana's valuation, stock price, and market status.
Is Anumana a public or private company?
Anumana is a private company.
What is the current stock price of Anumana?
Anumana is a private company, so its shares have no public market price. Caplight tracks Anumana's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Anumana worth (valuation)?
Valuation information for Anumana is not publicly available.
Can I buy Anumana stock?
Anumana shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Anumana's last funding round?
Anumana's most recent funding round was Series C on April 24, 2025.
Who are the main investors in Anumana?
Key investors in Anumana include Matrix, Matrix Capital Management, NTTVC.
Will Anumana IPO soon?
No public IPO plans have been announced for Anumana.
How can I track Anumana secondary market activity?
Caplight tracks bids, offers, and trades in Anumana's shares on secondary markets.